Neurology Alert – January 1, 2009
January 1, 2009
View Issues
-
PBT2 for the Treatment of Alzheimer's Disease
This novel agent, which inhibits interactions between beta amyloid (Ab) and metal ions, holds promise as a therapeutic agent for Alzheimer's disease. -
Gingko for Preventing Alzheimer's? Forget It
Gingko biloba does not prevent Alzheimer's disease. -
A New Monoclonal Antibody in the Fight Against Multiple Sclerosis: Alemtuzumab
The monoclonal antibody alemtuzumab, that targets the CD52 receptor on lymphocytes, reduced acute exacerbations and early disability by 70%. -
IV Immunoglobulin in MS Patients with Corticosteroid Refractory Optic Neuritis
The use of sustained pulsed dosing of intravenous immunoglobulin (IVIG) may be useful for treating multiple sclerosis (MS) patients with corticosteroid refractory optic neuritis. -
Can Denture Cream Cause Neurological Disorders?
Excessive use of denture cream, which contains high concentrations of zinc, may cause copper deficiency nervous system syndromes. -
Amyloidosis and Neuropathy
Generalized autonomic failure (GAF) in the presence of a sensory neuropathy strongly suggests amyloidosis. -
Pharmacology Watch
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions. -
Clinical Briefs in Primary Care Supplement